Position in PRAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$183,742,793
-$45,248,592 QoQ
Shares Held
548,830
-22.8% QoQ
Ownership
1.97%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#17
of 308 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 98%
Shared 0%
None 1%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. PRAX ranks #11 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in PRAX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $183,742,793 | 548,830 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $228,991,385 | 710,734 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $211,088,070 | 716,184 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $31,430,113 | 593,021 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $9,502,963 | 225,992 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,712,986 | 177,264 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $21,502,238 | 279,395 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $16,089,333 | 279,620 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,418,034 | 130,997 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,018,707 | 98,635 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $158,368 | 92,613 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $176,560 | 153,531 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $615,394 | 760,686 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $1,712,295 | 719,452 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,548,307 | 1,122,603 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $1,459,439 | 595,690 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,424,805 | 139,550 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,494,953 | 75,886 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $2,013,171 | 108,879 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $1,579,136 | 86,386 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,265,156 | 99,669 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,616,244 | 65,726 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||